A Randomized Controlled Trial of Ethyl Glucuronide-Based Contingency Management for Outpatients With Co-Occurring Alcohol Use Disorders and Serious Mental Illness.

CONCLUSIONS: This is the first randomized trial utilizing an accurate and validated biomarker (EtG) to demonstrate the efficacy of contingency management for alcohol dependence in outpatients with serious mental illness. PMID: 28135843 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28135843?dopt=Abstract

Source: The American Journal of Psychiatry - January 30, 2017 Category: Psychiatry Authors: McDonell MG, Leickly E, McPherson S, Skalisky J, Srebnik D, Angelo F, Vilardaga R, Nepom JR, Roll JM, Ries RK Tags: Am J Psychiatry Source Type: research